Invivoscribe Technologies Inc

FDA Filings

This page includes the latest FDA filings for Invivoscribe Technologies Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P160040S009 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2021-08-11
PMA P160040S008 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2021-08-05
PMA P160040S006 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2020-05-14
PMA P160040S004 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2018-12-21
PMA P160040S003 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2018-12-07
PMA P160040S002 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2018-11-28
PMA P160040S001 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2018-01-19
PMA P160040 INVIVOSCRIBE TECHNOLOGIES, INC	LeukoStrat CDx FLT3 Mutation Assay	2017-04-28

Similar & Related FDA Registered Companies

• INVIVOSCRIBE TECHNOLOGIES, INC10222 Barnes Canyon Road, Building 1san Diego, CA 92121 PMA NumberP160040 Supplement NumberS010 Date Received03/15/2022 Decision Date04/11/2022 Product Code OWD  Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No